This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (1634) JMIR Theme Issue: COVID-19 Special Issue (2437) Outbreak and Pandemic Preparedness and Management (1713) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1512) Diabetes Health Services and System Innovations (116) Telemedicine for Diabetes (92)

Published on in Vol 23, No 4 (2021): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24552, first published .
Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study

Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study

Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study

Authors of this article:

Martina Parise1 Author Orcid Image ;   Linda Tartaglione2 Author Orcid Image ;   Antonio Cutruzzolà1 Author Orcid Image ;   Maria Ida Maiorino3 Author Orcid Image ;   Katherine Esposito3 Author Orcid Image ;   Dario Pitocco2 Author Orcid Image ;   Agostino Gnasso4 Author Orcid Image ;   Concetta Irace5 Author Orcid Image
Article Authors Cited by (18) Tweetations (2) Metrics

Journals

  1. Minuto N, Bassi M, Montobbio C, Vinci F, Mercuri C, Perri F, Cabri M, Calevo M, d’Annunzio G, Maghnie M. The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes. Frontiers in Endocrinology 2021;12 View
  2. Kirzhner A, Zornitzki T, Ostrovsky V, Knobler H, Schiller T. Is Telemedicine the Preferred Visit Modality in Patients with Type 1 Diabetes?. Experimental and Clinical Endocrinology & Diabetes 2022;130(07):462 View
  3. Herle M, Brunner-Krainz M, Karall D, Goeschl B, Möslinger D, Zobel J, Plecko B, Scholl-Bürgi S, Spenger J, Wortmann S, Huemer M. A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria. Orphanet Journal of Rare Diseases 2021;16(1) View
  4. Wafa I, Pratama N, Sofia N, Anastasia E, Konstantin T, Wijaya M, Wiyono M, Djuari L, Novida H. Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal 2022;46(2):260 View
  5. Alharthi S, Alrajeh A, Alyusuf E, Alguwaihes A, Jammah A, Al-Sofiani M. “Pre-Ramadan” telemedicine: Effect on fasting experience and glycemic control during ramadan in people with type 1 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022;16(8):102567 View
  6. Grudziąż-Sękowska J, Sękowski K, Kobuszewski B. Healthcare Utilization and Adherence to Treatment Recommendations among Children with Type 1 Diabetes in Poland during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health 2022;19(8):4798 View
  7. Schiller T, Zornitzki T, Ostrovsky V, Sapojnik D, Cohen L, Kunyavski T, Knobler H, Kirzhner A. Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format. International Journal of Environmental Research and Public Health 2021;18(21):11309 View
  8. Negreiros F, Araújo A, Mattos S, Moreira T, Cestari V, Silva L, Moreira T. Digital technologies in the care of people with diabetes during the COVID-19 pandemic: a scoping review. Revista da Escola de Enfermagem da USP 2021;55 View
  9. Espinoza J, Xu N, Nguyen K, Klonoff D. The Need for Data Standards and Implementation Policies to Integrate CGM Data into the Electronic Health Record. Journal of Diabetes Science and Technology 2023;17(2):495 View
  10. Guzman G, Escobar M, Arias-Valderrama O, Guerra M, Martínez V. Clinical Experience of Using Telemedicine for the Management of Patients Using Continuous Subcutaneous Insulin Infusion in a Highly Complex Latin American Hospital. International Journal of Environmental Research and Public Health 2023;20(9):5719 View
  11. Bernocchi P, Crotti G, Beato E, Bonometti F, Giudici V, Bertolaia P, Perger E, Remuzzi A, Bachetti T, La Rovere M, Dalla Vecchia L, Angeli F, Parati G, Borghi G, Vitacca M, Scalvini S. COVID-19 teleassistance and teleconsultation: a matched case-control study (MIRATO project, Lombardy, Italy). Frontiers in Cardiovascular Medicine 2023;10 View
  12. Thomas C, Ramirez A, Alderfer M, Patton S, Carakushansky M, Enlow P. Telehealth and Type 1 Diabetes Care During COVID-19: Perceptions From Youth of Color, Caregivers, and Health Care Providers. Diabetes Spectrum 2023;36(3):245 View
  13. Sotomayor F, Hernandez R, Malek R, Parimi N, Spanakis E. The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era—A Systematic Review. Journal of Clinical Medicine 2023;12(17):5673 View
  14. Irace C, Acmet E, Cutruzzolà A, Parise M, Ponzani P, Scarpitta A, Candido R. Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform. Endocrine 2023;84(2):441 View
  15. Breidbart E, Gallagher M. Type 1 and Covid-19: Diagnosis, Clinical Care, and Health Outcomes during the Pandemic. Endocrinology and Metabolism Clinics of North America 2024;53(1):135 View
  16. Morat B, Lucidarme N, Gibert A, Harbulot C, Lachaume N, Gréteau S, Basmaci R. Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c. Frontiers in Pediatrics 2023;11 View
  17. Hatef E, Wilson R, Zhang A, Hannum S, Kharrazi H, Davis S, Foroughmand I, Weiner J, Robinson K. Effectiveness of telehealth versus in-person care during the COVID-19 pandemic: a systematic review. npj Digital Medicine 2024;7(1) View

Books/Policy Documents

  1. Schmitter-Edgecombe M, Luna C, Cook D. Positive Neuropsychology. View